Using HaCaT cells, it was shown that metformin inhibits the expression of inflammatory cytokines (IL-6 and TNF-α) and downregulates the growth factor VEGF thus inhibiting the inflammatory response in psoriasis by inhibiting mTOR [131]. Here, IL6 is linked to psoriasis.